Mechanism and Treatment Strategy of Osteoporosis after Transplantation

Chen, P. L., Wang, Y. F., Chuang, T. L., Chou, S. C., Liao, J. G., & Lin, C. H. (2020). The Prevalence of Osteoporosis in Patients With Low FRAX Risk. 核子醫學暨分子影像雜誌, 33(2), 88-98. https://doi.org/10.6332/ANMMI.202006_33(2).0003
林峰正、張維容、黃亮瑋、林慶揚、高木榮（2008）。Optimal Timing of Medical Intervention for Osteoporosis。北市醫學雜誌，5(1)，46-52。https://www.airitilibrary.com/Article/Detail?DocID=18102549-200802-5-1-46-52-a
Chen, J. L., Chang, F. C., Lee, C. Y., Huang, T. W., Huang, K. C., & Lee, M. S. (2017). Effects of anti-osteoporosis medications on osteoporotic hip fractures. Formosan Journal of Musculoskeletal Disorders, 8(4), 154-160. https://doi.org/10.6492/FJMD.20161014
吳俊男、蕭鈞百（2013）。Pharmacotherapy of Osteoporosis。南臺灣醫學雜誌，9(1)，6-14。https://doi.org/10.6726/MJST.201306_9(1).0002
余傑明、吳岱穎、楊榮森、廖振焜、樓亞洲、陳建志（2012）。Pharmacotherapy of Osteoporosis。台灣老年醫學暨老年學雜誌，7(2)，77-90。https://doi.org/10.29461/TGG.201205.0002